Please login to the form below

Not currently logged in
Email:
Password:

Merck's chair retires

Richard T Clark, chair of Merck (known as MSD outside the US and Canada) is to retire from the pharmaceutical company on December 1, 2011

Richard T Clark - MerckRichard T Clark, chair of Merck (known as MSD outside the US and Canada) is to retire from the pharmaceutical company on December 1, 2011.

He will be replaced by current CEO, Kenneth C Frazier who was elected by the board of directors.

Clark joined Merck in 1972 as a quality control inspector, and became chair in 2010. Other roles during his time at the company include president and CEO from 2005 to 2010, senior vice president of quality and commercial affairs, and president of the company's manufacturing division.

He said: "I have been a part of Merck for more than 39 years – I always have and always will consider Merck to be an important part of my life and my extended family. It has been a great pleasure to work with the talented, dedicated people of Merck who are so committed to our mission of saving and improving lives around the world."

During his time as CEO, Clark oversaw the successful launches of HIV treatment Isentress (raltegravir) and the HPV vaccine Gardasil.

He also led the company's $49bn merger with Schering-Plough in 2009.

10th October 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...
Medopad: the up and coming unicorn transforming remote patient monitoring
Blue Latitude Health speaks to Medopad’s Martha Carruthers to learn how the start-up’s modular apps are helping patients with complex diseases....

Infographics